Although no association of TIMP-2 gene polymorphisms with the increased risk of prostate cancer, cervical cancer, myocardial infarction (MI) or coronary artery disease (CAD), and relapsing-remitting multiple sclerosis (RRMS) was reported [29, 31–33]. Here, TIMP2 is linked to coronary artery disorder.